LITE Lumentum Holdings Inc

Previous close
$964.50
Est. 12 months change
+4.72%
Projected Price
$1,010.51

Profitability Metrics

Return on Equity (ROE)
28.04%
Return on Assets (ROA)
5.91%
Return on Invested Capital (ROIC)
7.12%
Weighted Average Cost of Capital (WACC)
13.17%
ROIC - WACC
-6.05%
Updated : 2026-05-21 20:17 ET

Valuation Metrics

P/E Ratio
180.99
Forward P/E
57.31
PEG Ratio
0.44
Debt Current Ratio
1.14

Growth & Cash Flow

Gross Margin
39.28%
Operating Margin
10.16%
FCF Margin
4.58%
TTM Revenue Growth
90.12%
Projected 12M EPS Growth
215.78%

Price Change

Price % from 50 SMA
35.78%
Price % from 200 SMA
174.06%
6 Months
387.12%
1 Year
1137.47%
2 Years
1640.80%
Click here to see the list of ETFs containing LITE as a top holding :LITE ETFs

Analysis

Company Overview

Lumentum Holdings develops optical and photonic products, including transceivers, lasers, and wavelength management components used in telecommunications and data centers. Sector: Technology.

Overview

Lumentum Holdings Inc (LITE) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

Through the lens of capital efficiency, ROIC is 7.12%, WACC is 13.17%, and the economic spread is -6.05%. On balance, the gap between operating returns and funding costs is unfavorable — a structural challenge that typically weighs on intrinsic value over time. Supporting metrics show ROE at 28.04% and ROA at 5.91%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that likely needs operating improvement before returns quality can be considered durable.

Valuation

On a multiple basis, the company trades at trailing P/E of 180.99, forward P/E of 57.31, PEG of 0.44. The trailing-to-forward compression is notable, pointing to an earnings growth narrative that, if delivered, would make current valuations more defensible. The PEG reading here is low enough to suggest investors are not being asked to overpay for the growth embedded in analyst estimates. The company's weighted current ratio of 1.14 suggests near-term liquidity is more constrained than average. The valuation setup is broadly consistent with a market that is pricing growth without being reckless about it — a balanced but not cautious stance.

Margins & Cash Generation

The margin profile breaks down as follows: gross margin sits at 39.28%, operating margin at 10.16%, and free cash flow margin at 4.58%. The gross margin profile here is adequate rather than impressive, consistent with more competitively priced industries. Operating margins are modest, suggesting overhead costs are consuming a meaningful share of gross profit. The company's FCF margin is minimal, suggesting the company are heavily reinvesting or facing meaningful capex demands. This stack calls for monitoring: profitability is present, but conversion from revenue to operating income to free cash is not fully consistent.

Growth & Forward Outlook

The near-term directional case rests on two inputs: TTM revenue growth of 90.12% pointing to healthy demand conditions for the company represented in the company. In parallel, analyst targets suggest limited near-term upside based on current consensus targets. The two figures measure different things — one reflects what businesses are actually delivering, the other what the market expects them to deliver. The extent to which these signals converge or diverge will likely be a primary driver of realized returns relative to current expectations. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The data points reviewed collectively point toward a positive outcome if execution holds — the setup is favorable even accounting for the inherent uncertainty in forward estimates.

The analysis above draws from quantitative data only and does not constitute personalized financial advice. Investors should conduct independent research and consider professional guidance before acting on any information presented here.